JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamada, S.
Right arrow Articles by Kimura, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamada, S.
Right arrow Articles by Kimura, R.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*PHENTOLAMINE
*TRITIUM

Vol. 289, Issue 3, 1575-1583, June 1999

In Vivo Measurement by [3H]Tamsulosin of alpha 1 Adrenoceptors in Rat Tissues in Relation to the Pharmacokinetics

Shizuo Yamada, Takashi Ohkura, Yoshiharu Deguchi and Ryohei Kimura

Department of Biopharmacy, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan

The present study was undertaken to simultaneously measure alpha 1 adrenoceptors in rat tissues by [3H]tamsulosin in vivo. In vivo specific [3H]tamsulosin binding was observed in the prostate, vas deferens, aorta, submaxillary gland, spleen, heart, lung, and kidney after i.v. injection of the ligand but not in the cerebral cortex and liver. Specific [3H]tamsulosin binding in the kidney, lung, heart, and spleen was greatest at 3 min after i.v. injection and declined rapidly with the disappearance of [3H]tamsulosin from the plasma. On the other hand, [3H]tamsulosin binding in the prostate and aorta peaked at 10 to 60 min after i.v. injection, and a considerable level of specific binding in both tissues persisted up to 240 min. The most sustained binding of [3H]tamsulosin occurred in the submaxillary gland. In vivo specific [3H]tamsulosin binding in rat tissues was effectively inhibited by the coinjection of low doses of unlabeled tamsulosin, prazosin, and terazosin with the radioligand but not by relatively high doses of yohimbine and propranolol. Based on estimated ID50 values, in vivo inhibitory effect of tamsulosin compared with prazosin was 5 to 14 times greater in rat tissues except the spleen, which showed 1.6 times less potent than prazosin. From ratios of ID50 (spleen) to ID50 (submaxillary gland) or ID50 (prostate), tamsulosin was 9 and 19 times, respectively, greater than prazosin in selectivity of alpha 1 adrenoceptors in the submaxillary gland and prostate versus the spleen, respectively, suggesting that tamsulosin binds to alpha 1A subtype with higher affinity than alpha 1B subtype in vivo. The present study suggests that [3H]tamsulosin is a useful radioligand for in vivo measurement of alpha 1 adrenoceptors in rat tissues.


0022-3565/99/2893-1575$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
T. Oki, A. Toma-Okura, and S. Yamada
Advantages for Transdermal over Oral Oxybutynin to Treat Overactive Bladder: Muscarinic Receptor Binding, Plasma Drug Concentration, and Salivary Secretion
J. Pharmacol. Exp. Ther., March 1, 2006; 316(3): 1137 - 1145.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
S. Yamada, T. Okura, R. Kimura, Y. Deguchi, Y. Suzuki, T. Kobayashi, and K. Aisaka
Disposition and alpha 1-Adrenoceptor Binding Characteristics of JTH-601 and Its Metabolites in Rat Tissues
Drug Metab. Dispos., April 13, 2001; 28(12): 1487 - 1492.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Yamada, T. Okura, and R. Kimura
In Vivo Demonstration of {alpha}1A-Adrenoceptor Subtype Selectivity of KMD-3213 in Rat Tissues
J. Pharmacol. Exp. Ther., January 1, 2001; 296(1): 160 - 167.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics.